作者
Clive Kearon, Jack Hirsh
发表日期
1997/5/22
来源
New England Journal of Medicine
卷号
336
期号
21
页码范围
1506-1511
出版商
Massachusetts Medical Society
简介
The most common indications for warfarin therapy are atrial fibrillation, the presence of a mechanical heart valve, and venous thromboembolism.1,2 Treatment with warfarin presents a problem if patients with these indications need surgery, because the interruption of anticoagulant therapy increases the risk of thromboembolism. After warfarin therapy is discontinued, it takes several days for its antithrombotic effect to recede, and when it is resumed, several days are needed to reestablish therapeutic anticoagulation.
There is no consensus on the appropriate perioperative management of anticoagulation for patients who have been receiving long-term warfarin therapy. Rational decisions about the treatment of such . . .
引用总数
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024321224633377751655868476943415939364043233034212512106
学术搜索中的文章